This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
TribLIVE
triblive.bsky.social
did:plc:fzlxtgq7lzuenqbsi23onkj7
Casgevy and Lyfgenia, the treatments approved by the FDA in late 2023, are one-time gene therapy treatments that use an individual’s blood stem cells to produce healthy fetal hemoglobin only made in the body during infancy.
https://triblive.com/news/health-now/breakthrough-treatments-offer-some-sickle-cell-sufferers-a-cure-barriers-remain/
2025-03-02T14:14:45.755Z